Search research articles
Contact Us
Filters
Showing results (31-40 of 144) with videos related to
Page
of 15
Sort By:
Pharmacotherapy
|
December 22, 2019
New and Worsening Long-term Immune-Related Adverse Events with PD-1/PD-L1 Pathway Agents in Patients with Cancer
Kevin H Hall, Yuan Liu, Chen Jiang, et al.
JAMA Oncology
|
April 21, 2022
Enabling the Sharing of Single-Dose Vials Through Risk Mitigation to Decrease Financial Toxicity
Daniel A Goldstein, R Donald Harvey, Kelvin K W Chan
Pharmacotherapy
|
May 1, 2016
Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events
Justin Lawson, Jeffrey M Switchenko, Trevor McKibbin, et al.
The New England Journal of Medicine
|
May 24, 2018
Rationale, Opportunities, and Reality of Biosimilar Medications
Gary H Lyman, Robin Zon, R Donald Harvey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials
Niamh Coleman, R Donald Harvey, David S Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2018
Reply to S.D. Lucio
Gary H Lyman, Robin Zon, R Donald Harvey, et al.
Journal of Pharmacy Practice
|
November 8, 2019
The Role of Pharmacists in Managing Adverse Events Related to Immune Checkpoint Inhibitor Therapy
Patrick Medina, Kate D Jeffers, Van A Trinh, et al.
Cancer
|
March 29, 2019
Reply to African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies
R Donald Harvey, Chao Zhang, Sagar Lonial, et al.
The Annals of Pharmacotherapy
|
December 29, 2021
Daratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations
Justin R Arnall, Kathryn T Maples, R Donald Harvey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 29, 2010
Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII
C L Kempton, S L Meeks, R Donald Harvey, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 144) with videos related to
Sort By:
Page
of 15
Pharmacotherapy
|
December 22, 2019
New and Worsening Long-term Immune-Related Adverse Events with PD-1/PD-L1 Pathway Agents in Patients with Cancer
Kevin H Hall, Yuan Liu, Chen Jiang, et al.
JAMA Oncology
|
April 21, 2022
Enabling the Sharing of Single-Dose Vials Through Risk Mitigation to Decrease Financial Toxicity
Daniel A Goldstein, R Donald Harvey, Kelvin K W Chan
Pharmacotherapy
|
May 1, 2016
Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events
Justin Lawson, Jeffrey M Switchenko, Trevor McKibbin, et al.
The New England Journal of Medicine
|
May 24, 2018
Rationale, Opportunities, and Reality of Biosimilar Medications
Gary H Lyman, Robin Zon, R Donald Harvey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2026
From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials
Niamh Coleman, R Donald Harvey, David S Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2018
Reply to S.D. Lucio
Gary H Lyman, Robin Zon, R Donald Harvey, et al.
Journal of Pharmacy Practice
|
November 8, 2019
The Role of Pharmacists in Managing Adverse Events Related to Immune Checkpoint Inhibitor Therapy
Patrick Medina, Kate D Jeffers, Van A Trinh, et al.
Cancer
|
March 29, 2019
Reply to African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies
R Donald Harvey, Chao Zhang, Sagar Lonial, et al.
The Annals of Pharmacotherapy
|
December 29, 2021
Daratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations
Justin R Arnall, Kathryn T Maples, R Donald Harvey, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 29, 2010
Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII
C L Kempton, S L Meeks, R Donald Harvey, et al.
Page
of 15